The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics
In order to develop new cancer therapeutics, rapid, reliable, and relevant biological models are required to screen and validate drug candidates for both efficacy and safety. In recent years, the zebrafish (<i>Danio rerio</i>) has emerged as an excellent model organism suited for these g...
Main Authors: | John T. Gamble, Daniel J. Elson, Juliet A. Greenwood, Robyn L. Tanguay, Siva K. Kolluri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/10/4/252 |
Similar Items
-
Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study
by: Patricia Letrado, et al.
Published: (2021-07-01) -
ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer
by: Carles Cornet, et al.
Published: (2019-12-01) -
Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment
by: Pablo Cabezas-Sáinz, et al.
Published: (2020-08-01) -
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform
by: Han-Syuan Lin, et al.
Published: (2019-05-01) -
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
by: Federica Tonon, et al.
Published: (2021-08-01)